Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-14

Clinical Trial Update: Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sulodexide for chronic subjective tinnitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulodexide (sulodexide)

Snippet

Sponsor: St Joseph University, Beirut, Lebanon | Conditions: Tinnitus, Subjective | Phase 2 | Status: COMPLETED